Bismuth quadruple therapy

DRUG7 trials

Conditions

Family History of Stomach CancerFirst-Line EradicationH. Pylori InfectionHelicobacterHelicobacter InfectionsHelicobacter Pylori InfectionHelicobatcer PyloriPeptic Ulcer

Phase 3

Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication

CompletedNCT02557932

National Cancer Center, KoreaFamily History of Stomach Cancer, Helicobacter Pylori Infection

Start: 2015-09-30End: 2019-09-28Updated: 2020-04-08

Phase 4

Sequential Therapy Versus Quadruple Therapy in H. Pylori Eradication

NCT03156855

National Taiwan University HospitalHelicobacter

Start: 2015-09-30End: 2019-12-31Target: 620Updated: 2017-05-17

Unknown Phase

Comparison of Hybrid and Bismuth Quadruple Therapies for Helicobacter Pylori Eradication

CompletedNCT02541864

Kaohsiung Veterans General Hospital.Helicobacter Pylori Infection

Start: 2013-07-31End: 2015-08-31Updated: 2017-11-24

A Comparison of Four Different Treatment Regimens of Helicobacter Pylori in Chinese Children

RecruitingNCT03365609

Ying HUANGHelicobacter Infections

Start: 2017-09-20End: 2025-12-31Target: 1440Updated: 2025-02-28

Efficacy Analysis of Saccharomyces Boulardii Combined With Minocycline in Treatment-naïve Patients With Helicobacter Pylori Infection

Not yet recruitingNCT07012785

Zhongda HospitalH. Pylori Infection

Start: 2025-06-30End: 2025-12-31Target: 208Updated: 2025-06-10

Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer Disease

RecruitingNCT07260006

Can Tho University of Medicine and PharmacyHelicobacter Pylori Infection, Peptic Ulcer

Start: 2024-10-01End: 2026-05-30Target: 80Updated: 2025-12-02

Efficacy And Safety of Bismuth-Tetracycline-Rabeprazole Triple For First-Line Eradication of Helicobacter Pylori Infection

Not yet recruitingNCT07788053

Chih-An Shih, MDFirst-Line Eradication, Helicobatcer Pylori

Start: 2026-09-01End: 2029-09-01Target: 300Updated: 2026-08-26

Related Papers

Ten-day bismuth-containing quadruple therapy versus 7-day proton pump inhibitor-clarithromycin containing triple therapy as first-line empirical therapy for the Helicobacter pylori infection in Korea: a randomized open-label trial.

2021-03-0214 citations

14 day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: a multicentre, non-inferiority, randomized trial.

2018-09-0123 citations

A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance

Antimicrobial Agents and Chemotherapy2017-08-1535 citations